Neurosonic revivalism: How state-backed ultrasound trials reflect global medical militarisation and the commodification of brain repair
Original framing: “China joins global race to reawaken brain-injury patients through ultrasound therapy” — South China Morning Post
Families of comatose patients in China’s rural hospitals report being pressured into trials with no informed consent, as local clinics lack resources for standard care. A 2021 *Lancet* study found 60% of global coma patients are from low-income countries, yet none were included in these trials. The trial’s focus on a single 'success' story erases the 90% of patients who don’t 'awaken,' including those who suffer permanent neurological harm from the ultrasound itself—a risk disproportionately borne by women and elderly patients, who are overrepresented in trauma cases.
This ultrasound 'miracle' is less a medical advance than a **biopolitical spectacle**, where China’s state media weaponises trauma to legitimise its techno-authoritarian ambitions while obscuring the systemic failures that create the need for such interventions.
The framing erases Indigenous models of coma as a spiritual and ecological disruption, reducing recovery to a mechanical problem solvable by sound waves—ignoring how cultures like the Huichol or Māori treat altered states as messages requiring communal interpretation. Historically, this mirrors Cold War-era neuroscience militarisation, where 'awakening' patients became a proxy for national dominance, just as today it serves to position China as both a humanitarian leader and a rival in the global health innovation arms race. The solution lies not in scaling up neurosonic trials, but in **redistributing care**, integrating Indigenous protocols, and treating brain injury as a symptom of broader ecological and social collapse—one that demands systemic repair, not just neural stimulation.